This article was co-authored by Fifa Rahman and PFAM coordinator Fran Quigley and was originally published in the Health and Human Rights Journal on February 18, 2018. To read the article at its original source, and with references hyperlinked, click here.
See the video folks, the President has said it himself. Although this is a clip from the campaign trail, Donald Trump, as a presidential candidate, called out the pharmaceutical industry. Mr. President, it's been almost half a year into your term as President and Pharma is still getting away with murder.
Last week, PFAM submitted a formal comment to the Federal Register on the President Donald J. Trump Administration's plan to renegotiate NAFTA. PFAM's major concern is that reopening of NAFTA could lead to more extended monopolies on medicines. Check out the comment here.
In the interview that accompanied President-elect Donald Trump’s Time magazine Person of the Year story, he said, “I’m going to bring down drug prices. I don’t like what has happened with drug prices.”
If you don’t find yourself agreeing with Trump very often, you may have finally found common ground. As the man said, there is a lot not to like.
Like everyone else in the U.S. and beyond, access to medicines advocates are trying to figure out just what the impact will be from last week’s surprising election results.
No one knows for sure, but it seems there is some bad news and some good news, and plenty of activism opportunities ahead...